Keywords: aredia, bone, metastases, breast, cancer, chiron, therapeutics

Aredia For Bone Metastases From Breast Cancer

Article | 19 August 1996

Print This

Chiron Therapeutics and Ciba have been granted approval in the USA to market their bisphosphonate drug Aredia (pamidronate disodium for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in